{
    "2019-11-23": [
        [
            {
                "time": "",
                "original_text": "【民生医药|周报】科创板（第27期）：百奥泰和成都先导过会，硕世生物和佰仁医疗将申购",
                "features": {
                    "keywords": [
                        "科创板",
                        "百奥泰",
                        "成都先导",
                        "硕世生物",
                        "佰仁医疗",
                        "过会",
                        "申购"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}